| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.095 | 0.04 |